Circulating exosomal PCAT1 as a complement of carcinoembryonic antigen for early colorectal cancer diagnosis
Serum exosomal PCAT1 can complement CEA assessment, aiding in early CRC diagnosis and helping to differentiate the disease, especially in patients with low CEA levels.
Authors
- Delan Luo
- Chao Wei (ORCID: https://orcid.org/0000-0003-1581-8377)
- Jianchao Zeng (ORCID: https://orcid.org/0000-0001-7755-7550)
- Jinghe Cao (ORCID: https://orcid.org/0000-0002-5194-5675)
- Hongli Pan (ORCID: https://orcid.org/0000-0001-9205-1232)
- Jiajia Mao
- Baoyu He (ORCID: https://orcid.org/0000-0002-5476-8651)
- Shishun Huang
- Jiashu Li (ORCID: https://orcid.org/0000-0002-2598-5227)
- Zhi-Jiang Zhang (ORCID: https://orcid.org/0000-0002-5418-5771)
Institutions
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
- Fourth Affiliated Hospital of Guangxi Medical University (CN)
- First People's Hospital of Nanning (CN)
- Affiliated Hospital of Jining Medical University (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e39264
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Guangxi Province
- Jining Medical University
- Doctoral Foundation of Shandong Province